Why the Telix (ASX:TLX) share price is rising this morning

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move today after the company announced it has inked a new deal. Here’s the details.

| More on:
Five stacked building blocks with green arrows, indicating rising inflation or share prices

Image source: Getty Images

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move today. This follows the biotechnology company’s announcement that it has inked a new lucrative deal.

At the time of writing, the Telix Pharmaceuticals share price is trading for $4.17, up 0.48%. 

What did Telix announce?

According to this morning’s release, Telix advised it has entered into an exclusive commercial distribution agreement with Eckert & Ziegler.

Founded in 1997, Berlin-based Eckert & Ziegler is one of the world’s largest providers of isotope technology for medical use. The company specialises in cancer therapy, industrial radiometry, and nuclear-medical imaging.

Under the deal, Telix’s prostate cancer imaging product, Illuccix, will be supplied to the German market through Eckert & Ziegler. This will occur once the expected marketing authorisation application has been approved by German health authorities. It is expected that the green light will be given sometime in later this year.

Comments from the CEO

Telix CEO Dr. Christian Behrenbruch commented:

We are pleased to have entered this commercial distribution agreement with Eckert & Ziegler so that, subject to German regulatory approval, we will together be able to bring this highly anticipated imaging agent to German patients living with prostate cancer as efficiently as possible.

Eckert & Ziegler executive member of the board, Dr Harald Hasselmann added:

This commercial partnership with Telix will enable us to open the door to state-of-the-art PSMA imaging for the 68,000 men diagnosed with prostate cancer each year in Germany.

Addressable market for prostate cancer in Germany

A published report from Globocan stated that prostate cancer was the most commonly diagnosed cancer across Germany in 2020. Roughly 68,000 cases were recorded last year. That is almost double the rate of lung cancer patients – around 38,000.

The findings also noted that prostate cancer caused the second most common deaths in men in Germany. Over 15,000 men died from the disease in 2020. Additionally, more than 290,000 German men are living with prostate cancer.

Telix share price summary

Telix shares have been an outstanding performer over the last 12 months, gaining close to 200% for shareholders.

Based on today’s prices, Telix presides a market capitalisation of roughly $1.1 billion, with approximately 281 million shares outstanding.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

retirement investing represented by older investor looking concerned at computer screen
Healthcare Shares

Why is the Medibank share price struggling to gain ground in May?

We check what's going on with shares in the private health insurer.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Healthcare Shares

Here’s why the Imugene share price just got a boost

Imugene's latest announcement is rallying up investors.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Healthcare Shares

Why the AnteoTech share price is rocketing 33% today

What did AnteoTech update the ASX with?

Read more »

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Growth Shares

Why CSL shares are ‘going to deliver’ in 2022: fund manager

Quality growth companies can perform well even in an era of rising interest rates.

Read more »

a group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
Healthcare Shares

Incannex share price pops 9% on FDA news

The medicinal cannabis drug development company came out with some positive developments from its FDA meeting...

Read more »

Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratory
Broker Notes

Where next for the CSL share price?

CSL shares could be heading higher according to one leading broker...

Read more »

A telehealth doctor at her desk.
Healthcare Shares

Why is the Ramsay share price smashing the ASX 200 on Monday?

Ramsay shares are off to a positive start today.

Read more »

a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

What’s going on with the Polynovo share price today?

The strong start has dissipated for Polynovo shares.

Read more »